Walmart Q2 FY26: Growth Is Intact, But Profit Pressure Weighed On Shares — Neutral

WMT   Seeking Alpha — August 21, 2025

Walmart Inc. shows strong sales and traffic growth, especially in grocery and digital, but faces pressure from cautious consumer spending on non-essentials. International operations and eCommerce are key growth drivers, yet profitability is challenged by higher costs and currency headwinds. The stock trades at a steep premium, reflecting high expectations for margin expansion and flawless execution, making valuation risk significant.

image for news Walmart Q2 FY26: Growth Is Intact, But Profit Pressure Weighed On Shares

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Replimune To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Replimune between November 22, 2024 and July 21, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 21, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Replimune Group, Inc. ("Replimune" …

image for news SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune

Workers say the executive was volatile and retaliated when they cooperated with an investigation. Apple denies the claims.

image for news Apple Fitness Chief Accused of Toxic Workplace Culture and Harassment

Coty shares slump on surprise second quarter loss — Negative

COTY   Proactive Investors — August 21, 2025

Coty Inc (NYSE:COTY) reported a surprise loss for the fiscal fourth quarter, sending its shares more than 20% lower on Thursday. The beauty brand reported a loss of $72.1 million, an improvement from a loss of $100.2 million in the year-ago period but worse than expectations of a profit of $37.6 million.

image for news Coty shares slump on surprise second quarter loss

PHILADELPHIA , Aug. 21, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Altimmune Inc. (NASDAQ: ALT) ("Altimmune" or the "Company") on behalf of investors who purchased or otherwise acquired publicly traded securities of Altimmune between August 10, 2023 through June 25, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired Altimmune securities during the Class Period may, no later than October 6, 2025 , seek to be appointed as a lead plaintiff representative of the class.

image for news INVESTOR REMINDER: Berger Montague Notifies Altimmune, Inc. (NASDAQ: ALT) Investors of a Class Action Lawsuit and Deadline

Citi takes a look at Amazon's entry into the car business.

image for news Amazon Is Getting Into The Car Business. Who That Hurts, and Helps.

Bob Iger, Disney CEO, and Jimmy Pitaro, ESPN chairman, join CNBC's 'Squawk on the Street' to discuss ESPN's new direct-to-consumer platform, how the success of the app will be measured, and much more.

image for news Disney CEO Bob Iger: We believe the new app will ‘contribute nicely' to ESPN's bottom line over time

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (Aug 2025) — Negative

NVO   24/7 Wall Street — August 21, 2025

Among all the weight loss drugs, Ozempic has become a phenomenon. With as much as $17 billion in sales in 2024 and over $10 billion in the first half of 2025, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo Nordisk A/S (NYSE: NVO).

image for news Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (Aug 2025)

IGLB: Long Duration And Tight Spreads Will Result In Tears — Negative

IGLB   Seeking Alpha — August 21, 2025

IGLB faces significant downside risk as investment-grade spreads are at their tightest since 1998, leaving little room for further tightening. Long-dated yields may remain elevated even if the Fed cuts rates, due to inflation and macroeconomic pressures, limiting capital gains potential for IGLB. The ETF's heavy exposure to lower investment-grade bonds (A/BBB) increases vulnerability to spread widening and potential drawdowns.

image for news IGLB: Long Duration And Tight Spreads Will Result In Tears

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Altimmune To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Altimmune between August 10, 2023 and June 25, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 21, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Altimmune, Inc. ("Altimmune" or …

image for news SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In iRobot To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in iRobot between January 29, 2024 and March 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 21, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against iRobot Corporation ("iRobot" or …

image for news SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRobot Corporation

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Unicycive To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Unicycive between March 29, 2024 and June 27, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 21, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Unicycive Therapeutics, Inc. ("Unicycive" …

image for news SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics

Why BitMine's Massive Discount Could Signal a Major Opportunity — Positive

BMNR   MarketBeat — August 21, 2025

A striking paradox is unfolding on the public markets, creating a situation that is commanding investor attention. BitMine Immersion Technologies NYSEAMERICAN: BMNR (BitMine), a company that has boldly reshaped its entire corporate identity, now controls a digital asset and cash treasury valued at over $6.6 billion.

image for news Why BitMine's Massive Discount Could Signal a Major Opportunity

Walmart Stock Stumbles on Rare Earnings Letdown — Negative

WMT   Schaeffers Research — August 21, 2025

Shares of Walmart Inc Inc (NYSE:TJX) are down 4.3% to trade at $98.15, after the retailer missed earnings estimates for the first time since 2022, reporting profits of 68 cents per share.

image for news Walmart Stock Stumbles on Rare Earnings Letdown

UnitedHealth's turnaround efforts underway — Positive

UNH   CNBC Television — August 21, 2025

CNBC's Bertha Coombs joins 'Squawk on the Street' with the latest details on UnitedHealth Group's turnaround efforts after a tumultuous year for the company.

image for news UnitedHealth's turnaround efforts underway

TriNet Deserves An Upgrade To "Buy" On Better Margins Ahead — Positive

TNET   Seeking Alpha — August 21, 2025

I'm upgrading TNET to 'Buy' as margin recovery and improved execution signal undervaluation, with a forward EV/EBITDA of ~7.1x and strong FCF yield. Recent earnings beat estimates despite YoY declines, and repricing efforts are driving insurance cost ratio back toward target by FY2026. EBITDA margin is set to recover to 10-11% by FY2026, supporting a bullish reversal in the stock price as valuation premium has faded.

image for news TriNet Deserves An Upgrade To "Buy" On Better Margins Ahead

ETF 360: John Lawlor Unpacks the State of Munis — Neutral

MMIT   ETF Trends — August 21, 2025

On the latest ETF 360, Kirsten Chang spoke to John Lawlor, managing director, portfolio manager/trader from MacKay Shields about the state of munis. Additionally, they discussed the NYLI MacKay Muni Intermediate ETF (MMIT).

image for news ETF 360: John Lawlor Unpacks the State of Munis

The Smart Money Is Wagering on This Sports Betting ETF — Positive

BETZ   ETF Trends — August 21, 2025

The regular college and professional football seasons are just around the corner. The smart money is betting on further upside with the Roundhill Sports Betting & iGaming ETF (BETZ).

image for news The Smart Money Is Wagering on This Sports Betting ETF

Value Outshines Growth: 5 ETF Winners Over the Past Week — Positive

GVLU  IWD  IWF  MTUM  RFV  RZV  SPVU  VLU   Zacks Investment Research — August 21, 2025

Value ETFs witness a surge as tech falters, with SPVU, RPV, RZV, RFV and GVLU gaining on rate cut bets and rotation into defensive sectors.

image for news Value Outshines Growth: 5 ETF Winners Over the Past Week

Best Momentum Stock to Buy for August 21st — Positive

ANET  BZ  OPRX   Zacks Investment Research — August 21, 2025

OPRX, BZ and ANET made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 21, 2025.

image for news Best Momentum Stock to Buy for August 21st